Get your free Adverum Biotechnologies Inc stock live and up-to-date data - ADVM Quote, charts, rates, analysis, news & forecasts. Enter Now! 5 brokers rate it as a 'Buy'. Click to view NMQ:ADVM's StockReport. StockRank ™ · StockReport™. Tools Latest News for ADVM. View all news. 13th Mar We apologize for any inconvenience. Refresh or try again later. Summary. News. Profile. Financials. Events. Ownership. Options Should you invest in Adverum Biotechnologies (NasdaqGM:ADVM)? ADVM, NasdaqGM (Nasdaq Global Market), Yes, Common Stock, US, USD, Aug 2014. 10 Feb 2020 ADVM stock was up in early trading on February 10, 2020, after a Cantor Fitzgerald upgrade. Cantor Fitzgerald analyst Alethia Young 9trading Stocks @9TradingDotCom 14 Oct 2019. More. Copy link $ADVM Posted the news as soon as it dropped and told my team about the cup and handle.
Adverum Biotechnologies, Inc. (ADVM): What ... - US Post News
In depth view into ADVM (Adverum Biotechnologies) stock including the latest price, news, dividend history, earnings information and financials. ADVM Stock Analysis: Price, Forecast, and News ADVM Stock Analysis Overview . What this means: Adverum Biotechnlgs (ADVM) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 76 means that our comprehensive methodology rates Adverum Biotechnlgs above 76% of stocks. Who this matters to: Overall Ranking is a comprehensive evaluation. It considers ADVM Adverum Biotechnologies, Inc. Stock Quote Shareholder Alert - Adverum Biotechnologies - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM GlobeNewswire 07:28AM Announcing: Adverum Biotechnologies (NASDAQ:ADVM) Stock Increased An Energizing 264% In The Last Three Years Simply Wall St.
8 analysts have issued twelve-month target prices for Adverum Biotechnologies' shares. Their forecasts range from $13.00 to $21.00. On average, they expect
Get your free Adverum Biotechnologies Inc stock live and up-to-date data - ADVM Quote, charts, rates, analysis, news & forecasts. Enter Now!